Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cancer Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cancer Genetics Inc (CGIX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 Feb 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for CGIX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

CANCER GENETICS INC (CGIX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company whic...

20 Jan 2016 GlobalData 60 $300.00

Wright Investors Service Comprehensive Report for Cancer Genetics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Jan 2016 Wright Reports 55 $75.00

CGIX- Recent discussions with management recap – profitability a focus

Recent discussions with management recap – profitability a focus

22 Dec 2015 Feltl & Company 7 $58.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company whic...

10 Dec 2015 GlobalData 63 $300.00

3Q15 Revenue Up 24% YoY

Strong 3Q15 revenue growth of 24% YoY. 3Q15 revenue grew 24% YoY to $4.0 million. This growth was driven primarily by increas...

04 Dec 2015 RedChip Companies, Inc. 5 $10.00

Receives Approval to Purchase Assets of Response Genetics

On October 2, 2015, CGIX announced that it received approval from the United States bankruptcy court in Delaware to purchase ...

04 Dec 2015 RedChip Companies, Inc. 4 $10.00